1. Home
  2. QNC vs CGC Comparison

QNC vs CGC Comparison

Compare QNC & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QNC

Quantum eMotion Corp. Common Shares

N/A

Current Price

$2.07

Market Cap

434.7M

Sector

N/A

ML Signal

N/A

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$0.93

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNC
CGC
Founded
2007
N/A
Country
Canada
Canada
Employees
5
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
434.7M
401.0M
IPO Year
2026
2023

Fundamental Metrics

Financial Performance
Metric
QNC
CGC
Price
$2.07
$0.93
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
4.2M
Earning Date
04-28-2026
05-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
84.17
EPS
N/A
N/A
Revenue
N/A
$12,759,000.00
Revenue This Year
N/A
$8.27
Revenue Next Year
N/A
$15.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.90
$0.84
52 Week High
$3.59
$2.38

Technical Indicators

Market Signals
Indicator
QNC
CGC
Relative Strength Index (RSI) 27.63 41.47
Support Level $1.90 $0.91
Resistance Level $3.01 $1.08
Average True Range (ATR) 0.18 0.04
MACD -0.09 0.00
Stochastic Oscillator 0.88 12.89

Price Performance

Historical Comparison
QNC
CGC

About QNC Quantum eMotion Corp. Common Shares

Quantum eMotion Inc is dedicated to developing of a new generation of quantum-safe encryption for the quantum computing age. It is a developer of a new generation of cryptographic solutions under the acquisition of licenses. It allows clients and partners to develop secure quantum-safe encryption that can protect anything from consumer and enterprise devices like mobile phones, computers, the Internet of Things, and networking equipment to demanding cloud-based applications, servers, and military devices.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: